| Literature DB >> 35232974 |
Aneta Teległów1, Jakub Marchewka1, Łukasz Tota2, Dawid Mucha3, Bartłomiej Ptaszek4, Robert Makuch5, Dariusz Mucha2.
Abstract
The importance of physical activity in preventing chronic cardiovascular and metabolic diseases and the role of exercise as an adjunct therapy are widely recognized. Triathlon is a typically endurance discipline. Prolonged and intensive exercise is known to cause changes in blood rheological properties and biochemical markers; sometimes athletes participating in strenuous competitions need medical attention. To understand the phenomena occurring in the body in such situations, we decided to study participants' biomarkers after the XTERRA Poland 2017 triathlon competition. The study involved 10 triathletes. The XTERRA Poland 2017 event comprised 1500-m swimming, 36-km cycling, and 10-km mountain running. Blood samples were collected 2 days before, immediately after, and 16 h after the competition. Immediately after the race, white blood cells count, platelets, and uric acid levels were significantly (P < 0.001) increased; haematocrit, Na+, Cl-, and IgA were decreased. On the following day, Na+, Cl-, and C-reactive protein levels were significantly (P < 0.001) increased; white blood cells count, red blood cells count, haemoglobin, haematocrit, mean corpuscular volume, platelets, IgG, and IgA were decreased. Assessing rheological parameters such as erythrocyte deformability and aggregation is useful for monitoring adverse effects of intensive and exhaustive exercise. The study illustrates the change in blood rheological properties and biochemical markers after intensive physical effort. Despite these differences, the indicators were within the reference range for the general population, which may demonstrate normal body function in the studied triathletes.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35232974 PMCID: PMC8888667 DOI: 10.1038/s41598-022-07240-1
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Selected somatic indicators in the examined competitors.
| Group | BM (kg) | BH (cm) | LBM (kg) | FM (kg) | F% (%) |
|---|---|---|---|---|---|
| Competitors | 81.1 ± 3.0 | 181.7 ± 4.1 | 70.0 ± 2.9 | 11.1 ± 3.0 | 13.7 ± 2.6 |
BM body mass, BH body height, LBM lean body mass, FM fat mass, F% percentage of fat tissue.
Mean values (± SD) of blood morphology indicators in the 3 performed measurements (M).
| Parameter | Before triathlon | Immediately after triathlon | 16 h after triathlon | Post hoc | |||
|---|---|---|---|---|---|---|---|
| M1/2 | M2/3 | M1/3 | |||||
| WBC (109/l) | 6.25 ± 2.16 | 14.53 ± 3.73 | 7.50 ± 1.66 | * | * | * | 0.634 |
| RBC (1012/l) | 5.18 ± 0.23 | 4.89 ± 0.20 | 4.40 ± 0.18 | * | * | * | * |
| HGB (g/l) | 15.45 ± 0.81 | 14.54 ± 1.01 | 12.96 ± 0.87 | * | * | * | * |
| HCT (l/l) | 44.60 ± 1.89 | 41.71 ± 3.03 | 37.70 ± 2.25 | * | * | * | * |
| MCV (fl) | 86.21 ± 3.18 | 85.16 ± 3.50 | 85.70 ± 3.23 | * | * | 0.104 | 0.328 |
| MCH (fmol) | 29.67 ± 1.11 | 29.71 ± 1.11 | 29.47 ± 1.51 | 0.849 | |||
| MCHC (mmol/l) | 34.44 ± 0.91 | 34.89 ± 0.91 | 34.42 ± 1.63 | 0.723 | |||
| PLT (109/l) | 248.50 ± 44.64 | 269.63 ± 54.94 | 214.50 ± 43.81 | * | * | * | * |
*Significant difference (P < 0.05).
WBC white blood cells count, RBC red blood cells count, HGB haemoglobin, HCT haematocrit, MCV mean corpuscular volume, MCH mean corpuscular haemoglobin, MCHC mean corpuscular haemoglobin concentration, PLT platelets.
Percentage changes in plasma volume in the 3 performed measurements.
| Before triathlon versus immediately after triathlon | Immediately after triathlon versus 16 h after triathlon | Before triathlon versus 16 h after triathlon |
|---|---|---|
| − 10.94 ± 8.10 | − 19.41 ± 5.85 | − 31.20 ± 14.59 |
| Between the ‘before triathlon versus immediately after triathlon’ and ‘immediately after triathlon versus 16 h after triathlon’ changes: | ||
| Between the ‘before triathlon versus immediately after triathlon’ and ‘before triathlon versus 16 h after triathlon’ changes: | ||
| Between the ‘immediately after triathlon versus 16 h after triathlon’ and ‘before triathlon versus 16 h after triathlon’ changes: | ||
*Significant difference (P = 0.0020).
Mean values (± SD) of the elongation index at various levels of shear stress in the 3 performed measurements (M).
| Shear stress (Pa) | Before triathlon | Immediately after triathlon | 16 h after triathlon | Post hoc | |||
|---|---|---|---|---|---|---|---|
| M1/2 | M2/3 | M1/3 | |||||
| 0.30 | 0.06 ± 0.02 | 0.07 ± 0.02 | 0.04 ± 0.03 | 0.0837 | |||
| 0.58 | 0.08 ± 0.01 | 0.07 ± 0.02 | 0.06 ± 0.03 | 0.164 | |||
| 1.13 | 0.12 ± 0.01 | 0.10 ± 0.02 | 0.08 ± 0.04 | 0.134 | |||
| 2.19 | 0.19 ± 0.02 | 0.15 ± 0.03 | 0.12 ± 0.07 | * | 0.030 | 0.347 | * |
| 4.24 | 0.26 ± 0.03 | 0.21 ± 0.04 | 0.17 ± 0.09 | * | 0.010 | 0.286 | * |
| 8.23 | 0.33 ± 0.04 | 0.26 ± 0.05 | 0.21 ± 0.10 | * | 0.002 | 0.271 | * |
| 15.98 | 0.39 ± 0.04 | 0.30 ± 0.05 | 0.25 ± 0.13 | * | 0.002 | 0.271 | * |
| 31.03 | 0.45 ± 0.04 | 0.35 ± 0.06 | 0.28 ± 0.14 | * | 0.005 | 0.183 | * |
| 60.30 | 0.46 ± 0.06 | 0.38 ± 0.06 | 0.32 ± 0.14 | * | 0.040 | 0.313 | * |
*Significant difference (P < 0.05).
Mean values (± SD) of the aggregation index (AI), aggregation half-time (T1/2), and amplitude of aggregation (AMP) in the 3 performed measurements (M).
| Parameter | Before triathlon | Immediately after triathlon | 16 h after triathlon | |
|---|---|---|---|---|
| AI (%) | 19.29 ± 1.98 | 17.07 ± 3.38 | 18.02 ± 5.05 | 0.763 |
| T1/2 (s) | 2.47 ± 0.98 | 3.50 ± 1.88 | 3.26 ± 1.89 | 0.069 |
| AMP (au) | 60.92 ± 8.32 | 59.61 ± 17.96 | 65.40 ± 22.20 | 0.418 |
Mean values (± SD) of electrolyte concentrations in the 3 performed measurements (M).
| Parameter | Before triathlon | Immediately after triathlon | 16 h after triathlon | Post hoc | |||
|---|---|---|---|---|---|---|---|
| M1/2 | M2/3 | M1/3 | |||||
| Na+ (mmol/l) | 141.40 ± 1.71 | 139.88 ± 1.55 | 142.10 ± 0.99 | * | * | * | 0.541 |
| K+ (mmol/l) | 4.65 ± 0.23 | 4.56 ± 0.36 | 4.41 ± 0.31 | * | 0.513 | 0.171 | 0.022 |
| Cl– (mmol/l) | 105.28 ± 1.39 | 101.45 ± 2.89 | 104.69 ± 1.93 | * | * | * | 0.892 |
*Significant difference (P < 0.05).
Mean values (± SD) or medians (IQR) of renal function indicators in the 3 performed measurements (M).
| Parameter | Before triathlon | Immediately after triathlon | 16 h after triathlon | Post hoc | |||
|---|---|---|---|---|---|---|---|
| M1/2 | M2/3 | M1/3 | |||||
| Urea (mmol/l) | 6.12 ± 1.62 | 7.35 ± 1.76 | 6.95 ± 0.94 | 0.081 | |||
| Creatinine (mmol/l) | 89.79 ± 12.69 | 108.51 ± 17.63 | 92.13 ± 14.34 | * | * | * | 0.999 |
| Uric acid (μmol/l) | 307.27 ± 50.19 | 436.08 ± 78.76 | 382.18 ± 52.69 | * | * | * | * |
| eGFR (ml/min/1.73 m2) | 77.0 (73.0–90.0) | 67.0 (59.5–77.5) | 83.5 (65.0–90.0) | * | * | * | 0.972 |
*Significant difference (P < 0.05).
IQR interquartile range, eGFR estimated glomerular filtration rate.
Medians (IQR) of liver function indicators in the 3 performed measurements (M).
| Parameter | Before triathlon | Immediately after triathlon | 16 h after triathlon | Post hoc | |||
|---|---|---|---|---|---|---|---|
| M1/2 | M2/3 | M1/3 | |||||
| Total bilirubin (mol/l) | 9.65 (7.50–14.10) | 14.65 (10.00–17.20) | 19.05 (11.50–21.80) | * | 0.782 | 0.053 | * |
| AST (U/l) | 26.95 (22.90–34.20) | 30.35 (28.55–44.05) | 37.75 (31.90–67.20) | * | 0.327 | 0.120 | * |
| ALT (U/l) | 23.20 (20.80–29.20) | 22.70 (18.30–25.40) | 24.90 (18.50–29.00) | 0.419 | |||
| GGT (U/l) | 21.25 (14.90–24.50) | 18.40 (12.85–22.00) | 18.70 (13.90–24.20) | * | 0.803 | 0.091 | * |
*Significant difference (P < 0.05).
IQR interquartile range, AST aspartate transaminase, ALT alanine transaminase, GGT gamma-glutamyltransferase.
Mean values (± SD) or medians (IQR) of selected serum protein parameters in the 3 performed measurements (M).
| Parameter | Before triathlon | Immediately after triathlon | 16 h after triathlon | M1/2 | M2/3 | M1/3 | |
|---|---|---|---|---|---|---|---|
| Total protein (g/l) | 71.09 ± 2.50 | 71.40 ± 4.36 | 67.31 ± 2.63 | * | 0.910 | * | * |
| Albumin (g/l) | 44.73 ± 1.62 | 44.98 ± 2.30 | 42.59 ± 1.22 | * | 0.989 | * | * |
| Alpha-1-globulin (g/l) | 2.40 ± 0.33 | 2.34 ± 0.30 | 2.36 ± 0.27 | 1.000 | |||
| Alpha-2-globulin (g/l) | 5.73 ± 0.31 | 5.21 ± 0.65 | 5.43 ± 0.52 | * | * | 0.881 | * |
| Beta-1-globulin (g/l) | 4.20 ± 0.55 | 4.45 ± 0.50 | 3. 90 ± 0.42 | * | 0.855 | * | * |
| Beta-2-globulin (g/l) | 3.41 ± 0.53 | 3.38 ± 0.67 | 3.17 ± 0.54 | * | 0.240 | 0.240 | * |
| Gamma-globulin (g/l) | 10.69 ± 1.67 | 11.08 ± 1.92 | 9.91 ± 1.64 | * | 0.825 | * | * |
| A/G (g/l) | 1.70 ± 0.14 | 1.71 ± 0.15 | 1.74 ± 0.16 | 0.070 | |||
| IgG (g/l) | 12.71 ± 1.72 | 13.09 ± 2.01 | 11.89 ± 1.78 | * | 0.769 | * | * |
| IgA (g/l) | 2.58 ± 0.83 | 2.41 ± 0.75 | 2.07 ± 0.67 | * | < 0.001 | * | * |
| IgM (g/l) | 0.93 ± 0.28 | 0.95 ± 0.28 | 0.84 ± 0.27 | * | 0.108 | * | * |
| CRP (mg/l) | 0.71 (0.32–2.15) | 0.57 (0.19–1.44) | 7.05 (2.29–9.01) | * | 0.999 | 0.001 | < 0.001 |
*Significant difference (P < 0.05).
IQR interquartile range, A/G albumin/globulin ratio, CRP C-reactive protein.